| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
CASE REPORT |
Rheumatology Department, Sunderland Royal Hospital, Sunderland, UK
Correspondence to:
Correspondence to:
Dr A T Y Chan, Rheumatology Department, Battle Hospital, Oxford Road, Reading RG30 1AG, UK;
antonichan{at}hotmail.com
ABSTRACT
A case of necrotising fasciitis in a patient receiving infliximab, an antitumour necrosis factor alpha (TNF-
) agent for rheumatoid arthritis, is presented. A widespread confluent, erythematous, pustular skin rash was the presenting sign. There was no fever throughout this admission. ß-Haemolytic group A streptococcus was isolated from blood cultures and skin swabs. The adductor muscles and fascia around the site of a previous hip arthroplasty were necrotic on exploration. The case highlights the risk of severe sepsis in patients on anti-TNF- treatment.
Keywords: necrotising fasciitis; infliximab; rheumatoid arthritis; antitumour necrosis factor-alpha
Abbreviations: APTT, activated partial thromboplastin time; TNF-, tumour necrosis factor-alpha
This article has been cited by other articles:
|
|
 |
|
  N Viget, G Vernier-Massouille, D Salmon-Ceron, Y Yazdanpanah, and J-F Colombel Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis Gut, April 1, 2008; 57(4): 549 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Y Mok, S Y Wong, T M Chan, W M Tang, W S Wong, and C S Lau Necrotizing fasciitis in rheumatic diseases Lupus, June 1, 2006; 15(6): 380 - 383. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Deng, V. Harvey, B. Sina, D. Strobel, A. Badros, J. M. Junkins-Hopkins, A. Samuels, M. Oghilikhan, and A. Gaspari Interstitial Granulomatous Dermatitis Associated With the Use of Tumor Necrosis Factor {alpha} Inhibitors. Arch Dermatol, February 1, 2006; 142(2): 198 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kapetanovic, T. Saxne, A. Sjoholm, L. Truedsson, G. Jonsson, and P. Geborek Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatology, January 1, 2006; 45(1): 106 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K L Hyrich, A J Silman, K D Watson, and D P M Symmons Anti-tumour necrosis factor {alpha} therapy in rheumatoid arthritis: an update on safety Ann Rheum Dis, December 1, 2004; 63(12): 1538 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Somasekar and R Alcolado Genital condylomata in a patient receiving infliximab for Crohn's disease Postgrad. Med. J., June 1, 2004; 80(944): 358 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M Verea, J. Del Pozo, M T. Yebra-Pimentel, A. Porta, and E. Fonseca Psoriasiform Eruption Induced by Infliximab Ann. Pharmacother., January 1, 2004; 38(1): 54 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kane, P. V. Balint, F. Wood, and R. D. Sturrock Early diagnosis of pyomyositis using clinic-based ultrasonography in a patient receiving infliximab therapy for Behcet's disease Rheumatology, December 1, 2003; 42(12): 1564 - 1565. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
